SCHEMBL6248694

SCHEMBL6248694

Cc1ccc(P(CCCCCCCP(c2ccc(C)cc2)c2ccc(C)cc2)c2ccc(C)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.40
TDP1 Q9NUW8 2/20 0.40
CHRM2 P08172 1/20 0.34
IDO1 P14902 1/20 0.33
ALDH1A1 P00352 6/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MAPT P10636 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
HTT P42858 3/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2A6 P11509 1/20 0.31
TAAR1 Q96RJ0 1/20 0.31
PKM P14618 2/20 0.30
ATM Q13315 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15658107 1.00 ACHE (0.40) ACHETDP1CHRM2IDO1ALDH1A1
SCHEMBL6272328 1.00 ACHE (0.40) ACHETDP1CHRM2IDO1ALDH1A1
SCHEMBL6251068 1.00 ACHE (0.40) ACHETDP1CHRM2IDO1ALDH1A1
SCHEMBL6248131 0.97 ACHE (0.42) ACHETDP1CHRM2IDO1ALDH1A1
SCHEMBL6248043 0.92 ACHE (0.42) ACHETDP1CHRM2IDO1ALDH1A1
SCHEMBL17529907 0.91 HTT (0.44) ACHETDP1CYP2C9CYP2C19MAPT
SCHEMBL17529770 0.91 HTT (0.44) ACHETDP1CYP2C9CYP2C19MAPT
SCHEMBL17529786 0.91 HTT (0.44) ACHETDP1CYP2C9CYP2C19MAPT
SCHEMBL7886836 0.89 HTT (0.41) ACHETDP1ALDH1A1SMN1; SMN2MAPT
SCHEMBL6251363 0.87 ACHE (0.47) ACHETDP1IDO1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1153908-B1 Method for producing 1-menthol TAKASAGO PERFUMERY CO LTD (JP) 2005-08-24 EP disclosed
US-6342644-B1 MULTISTAGE PROCESS OF HYDROGENATION WITH PHOSPHINE COMPLEX TAKASAGO INTERNATIONAL CORPORATION (JP) 2002-01-29 US disclosed
US-20020007094-A1 Method for producing 1-menthol TAKASAGO INTERNATIONAL CORPORATION (JP) 2002-01-17 US disclosed
EP-1153908-A2 Method for producing 1-menthol Takasago International Corporation (JP) 2001-11-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007094-A1 Method for producing 1-menthol HRH4, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PHOSPHO1 ACHE 433/4885TDP1 4557/4885CHRM2 69/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.